GENESOFT PHARMACEUTICALS, INC. FORM OF STOCK OPTION AGREEMENTStock Option Agreement • February 13th, 2004 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances • California
GENOME THERAPEUTICS CORP. STOCK OPTION ASSUMPTION AGREEMENTStock Option Assumption Agreement • February 13th, 2004 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances
WHEREAS, GeneSoft has been acquired as of February 6, 2004 by Genome through merger of a wholly owned Genome subsidiary, Guardian Acquisition, Inc (“Merger Sub”), with and into GeneSoft (the “Merger”) pursuant to the Agreement and Plan of Merger and Reorganization dated as of November 17, 2003 by and among Genome, GeneSoft, Merger Sub and Luke Evnin, as Stockholders’ Representative (the “Merger Agreement”).
